J3060 HCPCS Level II code: Injection, taliglucerase alfa, 10 units

J3060 is the HCPCS code for “Injection, taliglucerase alfa, 10 units” in CMS’s October 2026 release, in effect from Oct 1, 2026.

Official description

J3060

Injection, taliglucerase alfa, 10 units

Short description: Inj, taliglucerase alfa 10 u

HCPCS · United States

Medicare details

The indicators CMS publishes with J3060 in its October 2026 file. They describe Medicare’s handling, not another payer’s.

Medicare coverage
Carrier judgment
Medicare pricing
Drugs
ASC
Approved for ambulatory surgical centers
Type of service
Medical care; Lump sum purchase of DME, prosthetics, orthotics
BETOS category
Other drugs
Added
Jan 1, 2014

Where J3060 sits

  1. 1J codesDrugs administered other than orally
  2. 2Active code J3060Injection, taliglucerase alfa, 10 units

Source and release

Data release
HCPCS Level II · October 2026
Effective date
Oct 1, 2026
Publisher
CMS

This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.

Frequently asked questions

What does HCPCS code J3060 mean?

J3060 is the HCPCS code for “Injection, taliglucerase alfa, 10 units” in CMS’s HCPCS Level II October 2026 release.

Does Medicare cover J3060?

CMS lists J3060’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.

Which HCPCS Level II release does this page use?

It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.